Bone Cancer Clinical Trial
Official title:
A Phase II Pilot Study of Cyclophosphamide, Doxorubicin, Vincristine Alternating With Irinotecan and Temozolomide in Patients With Newly Diagnosed Metastatic Ewing's Sarcoma
The outcome of patients with metastatic Ewings Sarcoma is poor with current standard of care chemotherapy, with less than 30% survival. Based on recent encouraging pediatric literature we have designed this trial to improve the outcome of patients with metastatic Ewings sarcoma using Irinotecan and Temozolomide in addition to standard chemotherapy.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT03905174 -
Massive Implants the Next Generation
|
N/A | |
Completed |
NCT00160719 -
HLA Sensitization Following Major Cortical Allograft Bone Procedures
|
Phase 4 | |
Completed |
NCT04974008 -
Osteosarcoma Maintenance Therapy With OST31-164
|
Phase 2 | |
Not yet recruiting |
NCT06070259 -
Insights Into Participating in Studies for Bone Cancer
|
||
Completed |
NCT01553539 -
Therapeutic Angiotensin-(1-7) in Treating Patients With Metastatic Sarcoma That Cannot Be Removed By Surgery
|
Phase 2 | |
Recruiting |
NCT03160274 -
Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
|
||
Active, not recruiting |
NCT02880319 -
Evaluating Stereotactic Body Radiation Therapy for Oligometastatic Disease of the Bone
|
Phase 2 | |
Completed |
NCT01135849 -
B-Receptor Signaling in Cardiomyopathy
|
N/A | |
Terminated |
NCT00960063 -
A Study of Robatumumab (SCH 717454, MK-7454) in Combination With Different Treatment Regimens in Pediatric Participants With Advanced Solid Tumors (P05883, MK-7454-006)
|
Phase 1 | |
Terminated |
NCT02443103 -
Study Evaluating the Biologic Activity of Guanabenz in Bone Metastasis
|
N/A | |
Recruiting |
NCT04028479 -
The Registry of Oncology Outcomes Associated With Testing and Treatment
|
||
Terminated |
NCT03525392 -
Study to Evaluate the Safety and Activity (Including Distribution) of 177Lu-3BP-227 in Subjects With Solid Tumours Expressing Neurotensin Receptor Type 1.
|
Phase 1 | |
Terminated |
NCT01541358 -
Sodium Fluoride PET/CT for the Evaluation of Skeletal Cancer
|
N/A | |
Completed |
NCT01091883 -
Study Comparing the Safety and Effectiveness of Magnetic Resonance Guided Focused Ultrasound (MRgFUS) and External Beam Radiation (EBRT) for Treatment of Metastatic Bone Tumors and Multiple Myeloma
|
N/A | |
Terminated |
NCT00127387 -
Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia
|
Phase 2/Phase 3 | |
Not yet recruiting |
NCT03106675 -
MR Imaging- Guided High Intensity Focused Ultrasound (HIFU) Therapy of Bone Metastases
|
N/A | |
Recruiting |
NCT05830084 -
Phase Ib / Regorafenib With Conventional Chemotherapy/Newly Diagnosed Patients/ Multimetastatic Ewing Sarcoma
|
Phase 1 | |
Completed |
NCT01085565 -
Focused Ultrasound Surgery in the Treatment of Pain Resulting From Metastatic Bone Tumors With the ExAblate 2100 Conformal Bone System
|
Phase 2 | |
Recruiting |
NCT04307914 -
Focused Ultrasound and RadioTHERapy for Noninvasive Palliative Pain Treatment in Patients With Bone Metastases
|
N/A | |
Terminated |
NCT01163539 -
Cyberknife Radiosurgery and Quality of Life
|
N/A |